These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12767411)

  • 1. A comparison between traditional methods and multilevel regression for the analysis of multicenter intervention studies.
    Moerbeek M; van Breukelen GJ; Berger MP
    J Clin Epidemiol; 2003 Apr; 56(4):341-50. PubMed ID: 12767411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized sample size determination formulas for experimental research with hierarchical data.
    Usami S
    Behav Res Methods; 2014 Jun; 46(2):346-56. PubMed ID: 24197710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient design of cluster randomized and multicentre trials with unknown intraclass correlation.
    van Breukelen GJ; Candel MJ
    Stat Methods Med Res; 2015 Oct; 24(5):540-56. PubMed ID: 21937473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient treatment allocation in two-way nested designs.
    Lemme F; van Breukelen GJ; Berger MP
    Stat Methods Med Res; 2015 Oct; 24(5):494-512. PubMed ID: 24030312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imputation strategies for missing continuous outcomes in cluster randomized trials.
    Taljaard M; Donner A; Klar N
    Biom J; 2008 Jun; 50(3):329-45. PubMed ID: 18537126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accounting for centre-effects in multicentre trials with a binary outcome - when, why, and how?
    Kahan BC
    BMC Med Res Methodol; 2014 Feb; 14():20. PubMed ID: 24512175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating relative risks in multicenter studies with a small number of centers - which methods to use? A simulation study.
    Pedroza C; Truong VTT
    Trials; 2017 Nov; 18(1):512. PubMed ID: 29096682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating Standardized Effect Sizes for Two- and Three-Level Partially Nested Data.
    Lai MH; Kwok OM
    Multivariate Behav Res; 2016; 51(6):740-756. PubMed ID: 27802077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the most powerful analysis method for school-based intervention studies with alcohol, tobacco, and other drug outcomes.
    Janega JB; Murray DM; Varnell SP; Blitstein JL; Birnbaum AS; Lytle LA
    Addict Behav; 2004 May; 29(3):595-606. PubMed ID: 15050677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimum number of clusters and comparison of analysis methods for cross sectional stepped wedge cluster randomised trials with binary outcomes: A simulation study.
    Barker D; D'Este C; Campbell MJ; McElduff P
    Trials; 2017 Mar; 18(1):119. PubMed ID: 28279222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robustness of parameter and standard error estimates against ignoring a contextual effect of a subject-level covariate in cluster-randomized trials.
    Korendijk EJ; Hox JJ; Moerbeek M; Maas CJ
    Behav Res Methods; 2011 Dec; 43(4):1003-13. PubMed ID: 21512874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of random effect ordinal regression model for outcome evaluation of two randomized controlled trials.
    Marinacci C; Schifano P; Borgia P; Perucci CA
    Stat Med; 2001 Dec; 20(24):3769-76. PubMed ID: 11782032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extending Goodman-Kruskal's gamma to the comparison of ordered treatments in multicenter clinical trials.
    Kianifard F; Chen M
    J Biopharm Stat; 1999 Aug; 9(3):521-9. PubMed ID: 10473035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for comparing event rates in intervention studies when the unit of allocation is a cluster.
    Donner A; Klar N
    Am J Epidemiol; 1994 Aug; 140(3):279-89; discussion 300-1. PubMed ID: 8030631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical issues in multisite effectiveness trials: the case of brief strategic family therapy for adolescent drug abuse treatment.
    Feaster DJ; Robbins MS; Horigian V; Szapocznik J
    Clin Trials; 2004; 1(5):428-39. PubMed ID: 16279281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomization model methods for evaluating treatment efficacy in multicenter clinical trials.
    Davis CS; Chung Y
    Biometrics; 1995 Sep; 51(3):1163-74. PubMed ID: 7548700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and statistical issues in multicenter trials of severe head injury.
    Choi SC; Bullock R
    Neurol Res; 2001; 23(2-3):190-2. PubMed ID: 11320598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardized mean differences in individually-randomized and cluster-randomized trials, with applications to meta-analysis.
    White IR; Thomas J
    Clin Trials; 2005; 2(2):141-51. PubMed ID: 16279136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and evaluation of multiregional trials with heterogeneous treatment effect across regions.
    Chen CT; Hung HM; Hsiao CF
    J Biopharm Stat; 2012 Sep; 22(5):1037-50. PubMed ID: 22946948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Random effects probit and logistic regression models for three-level data.
    Gibbons RD; Hedeker D
    Biometrics; 1997 Dec; 53(4):1527-37. PubMed ID: 9423267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.